SUDAN VIRUS DISEASE: MOLECULAR PATHOGENESIS, PHARMACOLOGICAL TARGETS AND EMERGING THERAPEUTIC STRATEGIES
A review of current understanding of SUDV molecular biology, host–pathogen interactions, and immunopathology with emerging pharmacological opportunities integrates current understanding of SUDV molecular biology, host–pathogen interactions, and immunopathology with emerging pharmacological opportunities.